These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 21906045

  • 21. The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome.
    Dragon-Durey MA, Blanc C, Marliot F, Loirat C, Blouin J, Sautes-Fridman C, Fridman WH, Frémeaux-Bacchi V.
    J Med Genet; 2009 Jul; 46(7):447-50. PubMed ID: 19435718
    [Abstract] [Full Text] [Related]

  • 22. Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome.
    Kavanagh D, Kemp EJ, Mayland E, Winney RJ, Duffield JS, Warwick G, Richards A, Ward R, Goodship JA, Goodship TH.
    J Am Soc Nephrol; 2005 Jul; 16(7):2150-5. PubMed ID: 15917334
    [Abstract] [Full Text] [Related]

  • 23. Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome.
    Szarvas N, Szilágyi Á, Csuka D, Takács B, Rusai K, Müller T, Arbeiter K, Réti M, Haris Á, Wagner L, Török S, Kelen K, Szabó AJ, Reusz GS, Morgan BP, Prohászka Z.
    Mol Immunol; 2016 Mar; 71():10-22. PubMed ID: 26826462
    [Abstract] [Full Text] [Related]

  • 24. The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome.
    Martinez-Barricarte R, Pianetti G, Gautard R, Misselwitz J, Strain L, Fremeaux-Bacchi V, Skerka C, Zipfel PF, Goodship T, Noris M, Remuzzi G, de Cordoba SR, European Working Party on the Genetics of HUS.
    J Am Soc Nephrol; 2008 Mar; 19(3):639-46. PubMed ID: 18235085
    [Abstract] [Full Text] [Related]

  • 25. Functional characterization of two novel non-synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients.
    Mohlin FC, Nilsson SC, Levart TK, Golubovic E, Rusai K, Müller-Sacherer T, Arbeiter K, Pállinger É, Szarvas N, Csuka D, Szilágyi Á, Villoutreix BO, Prohászka Z, Blom AM.
    Mol Immunol; 2015 Jun; 65(2):367-76. PubMed ID: 25733390
    [Abstract] [Full Text] [Related]

  • 26. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
    Bernabéu-Herrero ME, Jiménez-Alcázar M, Anter J, Pinto S, Sánchez Chinchilla D, Garrido S, López-Trascasa M, Rodríguez de Córdoba S, Sánchez-Corral P.
    Mol Immunol; 2015 Oct; 67(2 Pt B):276-86. PubMed ID: 26163426
    [Abstract] [Full Text] [Related]

  • 27. The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome.
    Martínez-Barricarte R, Heurich M, López-Perrote A, Tortajada A, Pinto S, López-Trascasa M, Sánchez-Corral P, Morgan BP, Llorca O, Harris CL, Rodríguez de Córdoba S.
    Mol Immunol; 2015 Aug; 66(2):263-73. PubMed ID: 25879158
    [Abstract] [Full Text] [Related]

  • 28. Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32.
    Esparza-Gordillo J, Goicoechea de Jorge E, Buil A, Carreras Berges L, López-Trascasa M, Sánchez-Corral P, Rodríguez de Córdoba S.
    Hum Mol Genet; 2005 Mar 01; 14(5):703-12. PubMed ID: 15661753
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient.
    Chan MR, Thomas CP, Torrealba JR, Djamali A, Fernandez LA, Nishimura CJ, Smith RJ, Samaniego MD.
    Am J Kidney Dis; 2009 Feb 01; 53(2):321-6. PubMed ID: 18805611
    [Abstract] [Full Text] [Related]

  • 31. Plasmatherapy in atypical hemolytic uremic syndrome.
    Loirat C, Garnier A, Sellier-Leclerc AL, Kwon T.
    Semin Thromb Hemost; 2010 Sep 01; 36(6):673-81. PubMed ID: 20865645
    [Abstract] [Full Text] [Related]

  • 32. Hemolytic uremic syndrome recurrence after renal transplantation.
    Loirat C, Fremeaux-Bacchi V.
    Pediatr Transplant; 2008 Sep 01; 12(6):619-29. PubMed ID: 18482212
    [Abstract] [Full Text] [Related]

  • 33. Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency.
    Lee BH, Kwak SH, Shin JI, Lee SH, Choi HJ, Kang HG, Ha IS, Lee JS, Dragon-Durey MA, Choi Y, Cheong HI.
    Pediatr Res; 2009 Sep 01; 66(3):336-40. PubMed ID: 19531976
    [Abstract] [Full Text] [Related]

  • 34. Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome.
    Bienaime F, Dragon-Durey MA, Regnier CH, Nilsson SC, Kwan WH, Blouin J, Jablonski M, Renault N, Rameix-Welti MA, Loirat C, Sautés-Fridman C, Villoutreix BO, Blom AM, Fremeaux-Bacchi V.
    Kidney Int; 2010 Feb 01; 77(4):339-49. PubMed ID: 20016463
    [Abstract] [Full Text] [Related]

  • 35. Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option?
    Hirt-Minkowski P, Schaub S, Mayr M, Schifferli JA, Dickenmann M, Frémeaux-Bacchi V, Steiger J.
    Nephrol Dial Transplant; 2009 Nov 01; 24(11):3548-51. PubMed ID: 19633317
    [Abstract] [Full Text] [Related]

  • 36. A newly identified mutation in the complement factor I gene not associated with early post-transplant recurrence of atypical hemolytic-uremic syndrome: a case report.
    Ranghino A, Tognarelli G, Basso E, Messina M, Manzione AM, Daidola G, Segoloni GP.
    Transplant Proc; 2013 Sep 01; 45(7):2785-7. PubMed ID: 24034049
    [Abstract] [Full Text] [Related]

  • 37. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 Sep 01; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 38. Atypical hemolytic uremic syndrome: telling the difference between H and Y.
    Goicoechea de Jorge E, Pickering MC.
    Kidney Int; 2010 Oct 01; 78(8):721-3. PubMed ID: 20877372
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Successful therapeutic plasma exchange in a 3.2-kg body weight neonate with atypical hemolytic uremic syndrome.
    Jung S, Kang ES, Ki CS, Kim DW, Paik KH, Chang YS.
    J Clin Apher; 2011 Oct 01; 26(3):162-5. PubMed ID: 21322001
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.